Effectiveness of CoronaVac in children 3–5 years of age during the SARS-CoV-2 Omicron outbreak in Chile

Jara, Alejandro; A. Undurraga, Eduardo; R. Zubizarreta, José; González, Cecilia; Acevedo, Johanna; Pizarro, Alejandra; Vergara, Verónica; E. Soto-Marchant, Mario; Gilabert, Rosario; Carlos Flores, Juan; Suárez, Pamela; Leighton, Paulina; Eguiguren, Pablo; Carlos Ríos, Juan; Fernández, Jorge; García-Escorza, Heriberto; Araos, Rafael

doi:10.1038/s41591-022-01874-4

Public

Effectiveness of CoronaVac in children 3–5 years of age during the SARS-CoV-2 Omicron outbreak in Chile

Published in Nature Medicine • May 23, 2022

Authors:

Alejandro Jara

Eduardo A. Undurraga

José R. Zubizarreta

Abstract

The outbreak of the B.1.1.529 lineage of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Omicron) has caused an unprecedented number of Coronavirus Disease 2019 (COVID-19) cases, including pediatric hospital admissions. Policymakers urgently need evidence of vaccine effectiveness in ch...

Subject

Medicine

Vaccination

Outbreak

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!